sharecast

{{ storiesRelated.title }}

Full List Of Stories
20 Nov
sage group sagelive
Friday preview: UK retail sales, Sage in the spotlight

The focus in financial markets at the end of the week will be on the latest retail sales and public sector borrowing figures scheduled for release in the UK.

19 Nov
coronavirus-resultats-prometteurs-pour-un-vaccin-experimental-de-moderna 20201116134028
Europe close: Rising Covid-19 infections drag on shares

European shares were lower at midday as investors fretted over rising coronavirus deaths in Japan, the US and on the Continent.

19 Nov
smurfit kappa corrugated packaging
Smurfit Kappa to tap markets for 650m euros to capitalise on growth opportunities

Smurfit Kappa has decided to raise funds in order to accelerate its investments and capitalise on the trends towards e-commerce and sustainable packaging for products, having identified between €1. 2-1. 4bn of investment opportunities to boost the group's competitive advantage.

19 Nov
housing house prices
Existing home sales jump past forecasts in October

Sales of second-hand homes in the States jumped past forecasts in October.

19 Nov
la-fed-fixe-les-besoins-de-fonds-propres-supplementaires-pour-les-grandes-banques-americaines
Philly Fed factory index holds up better than expected in November

Manufacturing sector activity in the US mid-Atlantic region was holding up better than expected in November, the results of a closely-followed survey revealed.

19 Nov
easyjet-cible-d-une-cyberattaque-les-donnees-de-9-millions-de-clients-exposees
Liberum upgrades Easyjet to 'buy' on self-help actions, hikes target price

Analysts at Liberum hiked their target price for shares of Easyjet and upgraded their recommendation from 'hold' to 'buy' on the back of the budget airline's moves to rein in non-fuel costs.

19 Nov
ep logo de astrazeneca
Berenberg stays at 'buy' on AstraZeneca, positive on antibody treatment

Analysts at Berenberg struck a positive note on AstraZeneca shares after the drugmaker published full immunogenicity data earlier in the session for its Covid-19 vaccine candidate, AZD 1222.